May 7, 2024
|
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
|
|
April 16, 2024
|
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
|
|
March 19, 2024
|
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
|
|
February 12, 2024
|
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
|
|